Macrophage polarization: The answer to the diet/inflammation conundrum?

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 5, 2012, Pages 387-392

  Dall'Asta, M ^a   Derlindati, E ^a   Ardigo D ^a   Zavaroni, I ^a   Brighenti, F ^a   Del Rio, D ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Dietary compounds; Inflammation; Macrophage polarization; Polyphenols

Indexed keywords

CONJUGATED LINOLEIC ACID; CYTOKINE; FLAVONOID; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; ATHEROSCLEROSIS; DIET; HUMAN; IMMUNOLOGY; INSULIN RESISTANCE; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM; NEOPLASM; OBESITY; SHORT SURVEY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATHEROSCLEROSIS; CYTOKINES; DIET; FLAVONOIDS; HUMANS; INSULIN RESISTANCE; LINOLEIC ACIDS, CONJUGATED; MACROPHAGE ACTIVATION; MACROPHAGES; NEOPLASMS; OBESITY;

EID: 84859991621     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2011.12.010     Document Type: Short Survey

References (42)

1. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686.
2. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35.
3. Takeshige K., Yamazaki S., Eto A., Kataoka K., Muta T. Masui. Mechanism of macrophage activation by LPS. Masui 2002, 51(Suppl):S50-S62.
4. Mills C.D., Kincaid K., Alt J.M., Heilman M.J., Hill A.M. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000, 164:6166-6173.
5. Cathcart M.K. Regulation of superoxide anion production by NADPH oxidase in monocyte/macrophage: contributions to atherosclerosis. Arterioscler Thromb Vasc Biol 2004, 24:23-28.
6. Cao Y., Brombacher F., Tunyogi-Csapo M., Glant T.T., Finnegan A. Interleukin-4 regulates proteoglycan-induced arthritis by specifically suppressing the innate immune response. Arthritis Rheum 2007, 56:861-870.
7. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604.
8. Lang R., Patel D., Morris J.J., Rutschman R.L., Murray P.J. Shaping gene expression in activated and resting primary macrophages by IL-10. J Immunol 2002, 169:2253-2263.
9. Jung M., Sabat R., Krätzschmar J., Seidel H., Wolk K., Schönbein C., et al. Expression profiling of IL-10-regulated genes in human monocytes and peripheral blood mononuclear cells from psoriatic patients during IL-10 therapy. Eur J Immunol 2004, 34:481-493.
10. Tiwari R.L., Singh V., Barthwal Mk Macrophages: an elusive yet emerging therapeutic target in atherosclerosis. Med Res Rev 2008, 28:483-544.
11. Bouhlel M.A., Derudas B., Rigamonti E., Dièvart R., Brozek J., Haulon S., et al. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 2007, 6:137-143.
12. Choudhury R.P., Lee J.M., Greaves D.R. Mechanisms of disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis. Nat Clin Pract Cardiovasc Med 2005, 2:309-315.
13. Chinetti-Gbaguidi G., Baron M., Bouhlel M.A., Vanhoutte J., Copin C., Sebti Y., et al. Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways. Circ Res 2011, 108:985-995.
14. Olefsky J.M., Glass C.K. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010, 72:219-246.
15. Zeyda M., Farmer D., Todoric J., Aszmann O., Speiser M., Györi G., et al. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes (Lond) 2007, 31:1420-1428.
16. Aron-Wisnewsky J., Tordjman J., Poitou C., Darakhshan F., Hugol D., Basdevant A., et al. Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab 2009, 94:4619-4623.
17. Kawanishi N., Yano H., Yokogawa Y., Suzuki K. Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice. Exerc Immunol Rev 2010, 16:105-118.
18. Yakeu G., Butcher L., Isa S., Webb R., Roberts A.W., Thomas A.W., et al. Low-intensity exercise enhances expression of markers of alternative activation in circulating leukocytes: roles of PPARγ and Th2 cytokines. Atherosclerosis 2010, 212:668-673.
19. Sica A., Larghi P., Mancino A., Rubino L., Porta C., Totaro M.G., et al. Macrophage polarization in tumour progression. Semin Cancer Biol 2008, 18:349-355.
20. Rolny C., Mazzone M., Tugues S., Laoui D., Johansson I., Coulon C., et al. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell 2011, 19:31-44.
21. Meisner F., Walcher D., Gizard F., Kapfer X., Huber R., Noak A., et al. Effect of rosiglitazone treatment on plaque inflammation and collagen content in nondiabetic patients: data from a randomized placebo-controlled trial. Arterioscler Thromb Vasc Biol 2006, 26:845-850.
22. Odegaard J.I., Ricardo-Gonzalez R.R., Goforth M.H., Morel C.R., Subramanian V., Mukundan L., et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007, 447:1116-1120.
23. Li A.C., Palinski W. Peroxisome proliferator-activated receptors: how their effects on macrophages can lead to the development of a new drug therapy against atherosclerosis. Annu Rev Pharmacol Toxicol 2006, 46:1-39.
24. Bai L., Gabriels K., Wijnands E., Rousch M., Daemen M.J., Tervaert J.W., et al. Low- but not high-dose FK506 treatment confers atheroprotection due to alternative macrophage activation and unaffected cholesterol levels. Thromb Haemost 2010, 104:143-150.
25. Stewart C.R., Stuart L.M., Wilkinson K., van Gils J.M., Deng J., Halle A., et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 2010, 11:155-161.
26. Toomey S., Harhen B., Roche H.M., Fitzgerald D., Belton O. Profound resolution of early atherosclerosis with conjugated linoleic acid. Atherosclerosis 2006, 187:40-49.
27. Hughes J.E., Srinivasan S., Lynch K.R., Proia R.L., Ferdek P., Hedrick C.C. Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages. Circ Res 2008, 102:950-958.
28. Lovren F., Pan Y., Quan A., Szmitko P.E., Singh K.K., Shukla P.C., et al. Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages. Am J Physiol Heart Circ Physiol 2010, 299:H656-H663.
29. Csóka B., Selmeczy Z., Koscsó B., Németh Z.H., Pacher P., Murray P.J., et al. Adenosine promotes alternative macrophage activation via A2A and A2B receptors. FASEB J 2011, [Epub ahead of print].
30. Tucsek Z., Radnai B., Racz B., Debreceni B., Priber J.K., Dolowschiak T., et al. Suppressing LPS-induced early signal transduction in macrophages by a polyphenol degradation product: a critical role of MKP-1. J Leukoc Biol 2011, 89:105-111.
31. Overman A., Bumrungpert A., Kennedy A., Martinez K., Chuang C.C., West T., et al. Polyphenol-rich grape powder extract (GPE) attenuates inflammation in human macrophages and in human adipocytes exposed to macrophage-conditioned media. Int J Obes (Lond) 2010, 34:800-808.
32. Calder P.C. Fatty acids and inflammation: the cutting edge between food and pharma. Eur J Pharmacol 2011, 668:S50-S58.
33. Song D.H., Kang J.H., Lee G.S., Jeung E.B., Yang M.P. Upregulation of tumor necrosis factor-alpha expression by trans10-cis12 conjugated linoleic acid enhances phagocytosis of RAW macrophages via a peroxisome proliferator-activated receptor gamma-dependent pathway. Cytokine 2007, 37:227-235.
34. Yu Y., Correll P.H., Vanden Heuvel J.P. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism. Biochim Biophys Acta 2002, 1581:89-99.
35. Pérez-Jiménez J., Neveu V., Vos F., Scalbert A. Identification of the 100 richest dietary sources of polyphenols: an application of the phenol-explorer database. Eur J Clin Nutr 2010, 64:S112-S120.
36. Boesch-Saadatmandi C., Loboda A., Wagner A.E., Stachurska A., Jozkowicz A., Dulak J., et al. Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. J Nutr Biochem 2011, 22:293-299.
37. Martinez-Micaelo N., González-Abuín N., Terra X., Richart C., Ardèvol A., Pinent M., et al. Omega-3 docosahexaenoic acid and procyanidins inhibit cyclooxygenase activity and attenuate NF-κB activation through a p105/p50 regulatory mechanism in macrophage inflammation. Biochem J 2011, [Epub ahead of print].
38. Hämäläinen M., Nieminen R., Asmawi M.Z., Vuorela P., Vapaatalo H., Moilanen E. Effects of flavonoids on prostaglandin E2 production and on COX-2 and mPGES-1 expressions in activated macrophages. Planta Med 2011, 77:1504-1511.
39. Yi C.O., Jeon B.T., Shin H.J., Jeong E.A., Chang K.C., Lee J.E., et al. Resveratrol activates AMPK and suppresses LPS-induced NF-kB-dependent COX-2 activation in RAW 264.7 macrophage cells. Anat Cell Biol 2011, 44:194-203.
40. Huebbe P., Giller K., de Pascual-Teresa S., Arkenau A., Adolphi B., Portius S., et al. Effects of blackcurrant-based juice on atherosclerosis-related biomarkers in cultured macrophages and in human subjects after consumption of a high-energy meal. Br J Nutr 2011, [Epub ahead of print].
41. Del Rio D., Costa L.G., Lean M.E., Crozier A. Polyphenols and health: what compounds are involved?. Nutr Metab Cardiovasc Dis 2010, 20:1-6.
42. Crozier A., Jaganath I.B., Clifford M.N. Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 2009, 26:1001-1043.